These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35810563)

  • 61. Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer.
    Abe N; Matsumoto H; Takamatsu R; Tamaki K; Takigami N; Uehara K; Kamada Y; Tamaki N; Motonari T; Unesoko M; Nakada N; Zaha H; Yoshimi N
    Virchows Arch; 2020 May; 476(5):701-709. PubMed ID: 31873876
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC.
    Rakaee M; Adib E; Ricciuti B; Sholl LM; Shi W; Alessi JV; Cortellini A; Fulgenzi CAM; Viola P; Pinato DJ; Hashemi S; Bahce I; Houda I; Ulas EB; Radonic T; Väyrynen JP; Richardsen E; Jamaly S; Andersen S; Donnem T; Awad MM; Kwiatkowski DJ
    JAMA Oncol; 2023 Jan; 9(1):51-60. PubMed ID: 36394839
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer.
    Ahn S; Chung YR; Seo AN; Kim M; Woo JW; Park SY
    PLoS One; 2020; 15(5):e0233037. PubMed ID: 32401825
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.
    Leon-Ferre RA; Polley MY; Liu H; Gilbert JA; Cafourek V; Hillman DW; Elkhanany A; Akinhanmi M; Lilyquist J; Thomas A; Negron V; Boughey JC; Liu MC; Ingle JN; Kalari KR; Couch FJ; Visscher DW; Goetz MP
    Breast Cancer Res Treat; 2018 Jan; 167(1):89-99. PubMed ID: 28913760
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Machine Learning Quantification of Intraepithelial Tumor-Infiltrating Lymphocytes as a Significant Prognostic Factor in High-Grade Serous Ovarian Carcinomas.
    Machuca-Aguado J; Conde-Martín AF; Alvarez-Muñoz A; Rodríguez-Zarco E; Polo-Velasco A; Rueda-Ramos A; Rendón-García R; Ríos-Martin JJ; Idoate MA
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003250
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer.
    Eriksen AC; Andersen JB; Kristensson M; dePont Christensen R; Hansen TF; Kjær-Frifeldt S; Sørensen FB
    Diagn Pathol; 2017 Aug; 12(1):65. PubMed ID: 28851404
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
    Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer.
    Dirican N; Karakaya YA; Gunes S; Daloglu FT; Dirican A
    Clin Respir J; 2017 Nov; 11(6):789-796. PubMed ID: 26619201
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
    Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
    Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs).
    Nguyen LT; Yen PH; Nie J; Liadis N; Ghazarian D; Al-Habeeb A; Easson A; Leong W; Lipa J; McCready D; Reedijk M; Hogg D; Joshua AM; Quirt I; Messner H; Shaw P; Crump M; Sharon E; Ohashi PS
    PLoS One; 2010 Nov; 5(11):e13940. PubMed ID: 21085676
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
    Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer.
    Horne ZD; Jack R; Gray ZT; Siegfried JM; Wilson DO; Yousem SA; Nason KS; Landreneau RJ; Luketich JD; Schuchert MJ
    J Surg Res; 2011 Nov; 171(1):1-5. PubMed ID: 21571304
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
    Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P
    Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of Tumor-Infiltrating Lymphocytes on Overall Survival in Merkel Cell Carcinoma.
    Butala AA; Jain V; Reddy VK; Sebro RA; Song Y; Karakousis G; Mitchell TC; Lukens JN; Shabason JE
    Oncologist; 2021 Jan; 26(1):63-69. PubMed ID: 32886418
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.
    Bottai G; Raschioni C; Losurdo A; Di Tommaso L; Tinterri C; Torrisi R; Reis-Filho JS; Roncalli M; Sotiriou C; Santoro A; Mantovani A; Loi S; Santarpia L
    Breast Cancer Res; 2016 Dec; 18(1):121. PubMed ID: 27912781
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma.
    Sudo T; Nishida R; Kawahara A; Saisho K; Mimori K; Yamada A; Mizoguchi A; Kadoya K; Matono S; Mori N; Tanaka T; Akagi Y
    Ann Surg Oncol; 2017 Nov; 24(12):3763-3770. PubMed ID: 28160141
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy.
    Luen SJ; Salgado R; Dieci MV; Vingiani A; Curigliano G; Gould RE; Castaneda C; D'Alfonso T; Sanchez J; Cheng E; Andreopoulou E; Castillo M; Adams S; Demaria S; Symmans WF; Michiels S; Loi S
    Ann Oncol; 2019 Feb; 30(2):236-242. PubMed ID: 30590484
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CD8⁺ tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma.
    Fujii H; Arakawa A; Utsumi D; Sumiyoshi S; Yamamoto Y; Kitoh A; Ono M; Matsumura Y; Kato M; Konishi K; Shiga T; Sano S; Sakaguchi S; Miyagawa-Hayashino A; Takahashi K; Uezato H; Miyachi Y; Tanioka M
    Int J Cancer; 2014 May; 134(10):2393-402. PubMed ID: 24243586
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort.
    Straker RJ; Krupp K; Sharon CE; Thaler AS; Kelly NJ; Chu EY; Elder DE; Xu X; Miura JT; Karakousis GC
    Ann Surg Oncol; 2022 Aug; 29(8):5207-5216. PubMed ID: 35301610
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic Significance of Tumor-Infiltrating Lymphocyte Grade in Melanoma: A Meta-Analysis.
    Sun Q; Sun H; Wu N; Cong L; Cong X
    Dermatology; 2020; 236(6):481-492. PubMed ID: 32023619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.